Methotrexate in acute persistent humoral rejection: an option for graft rescue.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12902116.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Humoral response emerges as an important component in acute graft rejection and a new challenge to clinicians in posttransplant care. Management of recurrent episodes and persistent activation of the humoral component of the immune system, despite the usual therapeutic approach to rejection, remains unknown. This article describes the successful use of methotrexate as an option for rescuing a graft in this worrisome situation.
Medical subject headings
- Cardiomyopathy, Dilated
- Graft Rejection
- Heart Transplantation
- Methotrexate